Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • sformel
    Junior Member
    • Apr 2019
    • 4

    should primers be considered biological sequence?

    Hi,

    Forgive me if this is naive, but I'm still newish to thinking about sequencing. I've begun working with the DADA2 software and the tutorial clearly states that primers should be trimmed because they are non-biological nucleotides.

    I'm not arguing against it, but I don't fully understand it. If the primer matches a sequence of DNA, then shouldn't it be just as legitimate a sequence as the sequence derived from the sequencing process?

    Any thoughts?

    Thanks,
    Steve
  • jhalpin
    Member
    • Jan 2015
    • 26

    #2
    Primers and adapters are added to the fragments during the preparation of the samples. They are not native sequences and are extremely over represented compared to any natural occurrences of those short sequences.

    Comment

    • sformel
      Junior Member
      • Apr 2019
      • 4

      #3
      Thanks for the quick reply! But I'm still not sure I understand.

      My thought is that the because the primer matched the DNA fragment during PCR, it can be considered a legitimate copy of a biological sequence of nucleotides, just like the copy that is made during sequencing.

      But it seems from what you wrote that the problem is due to over representation of those sequences. How is a primer sequence different from a highly conserved region of an amplicon?

      To be clear, I'm coming at this from a metagenomics perspective, which may be skewing my thoughts.
      Last edited by sformel; 04-01-2019, 10:06 AM. Reason: picture was too large

      Comment

      • jhalpin
        Member
        • Jan 2015
        • 26

        #4
        Sorry.. in the lab to make sequencing libraries the primers are added. They aren't in the sequence of the thing you're looking at. The primers are constructed by a company and sold as part of the kit. Here's an overview of the lab side: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351865/

        Comment

        • sformel
          Junior Member
          • Apr 2019
          • 4

          #5
          Ok, I understand what you're saying in regards to RNA-seq type libraries.

          However, I'm working with a 2-step PCR in which the first step is an amplification of a marker gene, followed by an indexing PCR (addition of adapters and barcodes). So in my case, the primer is part of my biological sequence.

          In any case, I appreciate your thoughts. I'm going to think on it a little more and see if it clicks.

          Comment

          • cmbetts
            Senior Member
            • Jun 2012
            • 120

            #6
            That sequence isn't derived from the fragment you're trying to sequence. 100% of it was chemically synthesized by your oligo synthesis company. It match close enough to your insert of interest to prime it, but does not guarantee that the sequences were perfectly complementary. For instance, any mispriming artifacts will perfectly match your sequence of interest over the length of the primer...

            Comment

            • sformel
              Junior Member
              • Apr 2019
              • 4

              #7
              Ah ok, that makes sense. I didn't think about those kind of biases. Thanks for your help!

              Comment

              • ATϟGC
                Member
                • Jun 2013
                • 56

                #8
                I will just echo cmbetts in saying that you should always remove your oligo/primer sequences from Sanger and High-throughput sequencing data since they are artificial. You can sometimes find primer/oligo sequences in "cleaned" sequences archived in GenBank and other public databases but this is not a good practice.

                The only good reason I can think of off-hand to not trim the oligos is if you are archiving the raw data, in which case you should state the oligos used so others can trim them for downstream analyses.

                Comment

                Latest Articles

                Collapse

                • SEQadmin2
                  Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                  by SEQadmin2


                  Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                  The systematic characterization of the human proteome has
                  ...
                  07-20-2026, 11:48 AM
                • SEQadmin2
                  Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                  by SEQadmin2



                  Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                  ...
                  07-09-2026, 11:10 AM
                • SEQadmin2
                  Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                  by SEQadmin2



                  Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                  There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                  07-08-2026, 05:17 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, Today, 11:41 AM
                0 responses
                9 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-20-2026, 11:10 AM
                0 responses
                21 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-13-2026, 10:26 AM
                0 responses
                34 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-09-2026, 10:04 AM
                0 responses
                44 views
                0 reactions
                Last Post SEQadmin2  
                Working...